Flu Vaccinations in Pharmacies-A Review of Pharmacists Fighting Pandemics and Infectious Diseases.
Betacoronavirus
COVID-19
Communicable Disease Control
Community Pharmacy Services
Coronavirus Infections
/ epidemiology
Europe
Humans
Influenza, Human
/ prevention & control
Pandemics
/ prevention & control
Pharmacies
Pharmacists
/ psychology
Pneumonia, Viral
/ epidemiology
SARS-CoV-2
Vaccination
/ statistics & numerical data
COVID-19
flu
pharmacist
pharmacy
vaccination
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
29 10 2020
29 10 2020
Historique:
received:
06
10
2020
revised:
22
10
2020
accepted:
27
10
2020
entrez:
3
11
2020
pubmed:
4
11
2020
medline:
13
11
2020
Statut:
epublish
Résumé
The phenomenon of population ageing observed over recent years involves growing healthcare needs and the limited staffing and financing of healthcare systems, and as such demands some functional changes in the healthcare model in many countries. This situation is particularly significant in the face of a pandemic, e.g., flu, and currently COVID-19.As well as social education, preventive vaccinations are the most effective method of fighting the infectious diseases posing a special threat to seniors. Despite this, the vaccination coverage level in most European countries is relatively low. This is largely due to patients having limited access to vaccinations. In some countries, implementing vaccinations in pharmacies and by authorized pharmacists has significantly improved vaccination coverage rates and herd immunity, while lowering the cost of treating infections and the resulting complications, as well as minimizing the phenomenon of inappropriate antibiotic therapies. This article presents the role of pharmacists in the prevention of infectious diseases, pointing out the measurable effects of engaging pharmacists in conducting preventive vaccinations, as well as analyzing the models of implementing and conducting vaccinations in pharmacies in selected countries, and depicting recommendations regarding vaccinations developed by international organizations. The presented data is used to suggest requirements for the implementation of preventive vaccinations in community pharmacies.
Identifiants
pubmed: 33138198
pii: ijerph17217945
doi: 10.3390/ijerph17217945
pmc: PMC7662566
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Références
JAMA. 2017 May 16;317(19):1947-1948
pubmed: 28319233
Am Fam Physician. 2001 Jan 15;63(2):257-68
pubmed: 11201692
Res Social Adm Pharm. 2013 Nov-Dec;9(6):989-95
pubmed: 23591411
Vaccine. 2004 Feb 25;22(8):1001-6
pubmed: 15161077
Hum Vaccin Immunother. 2014;10(2):428-40
pubmed: 24165394
Hum Vaccin Immunother. 2016 Sep;12(9):2259-68
pubmed: 27166916
Int Nurs Rev. 2019 Mar;66(1):9-16
pubmed: 30039849
BMC Health Serv Res. 2014 Jan 24;14:35
pubmed: 24456532
Vaccine. 2016 Nov 11;34(47):5708-5723
pubmed: 27765379
Clin Ther. 2017 Aug;39(8):1563-1580.e17
pubmed: 28781217
J Health Econ. 2018 Jan;57:60-74
pubmed: 29182935
Crit Care. 2020 Feb 19;24(1):56
pubmed: 32070391
PLoS One. 2017 Jan 26;12(1):e0170550
pubmed: 28125629
Can Pharm J (Ott). 2014 Nov;147(6):359-65
pubmed: 25364353
Am J Health Syst Pharm. 2003 Jul 1;60(13):1371-7
pubmed: 12901040
Crit Care. 2020 Mar 16;24(1):91
pubmed: 32178711
BMC Health Serv Res. 2017 Aug 29;17(1):606
pubmed: 28851428